Fountain Therapeutics
PrivateLast Round
Series A
Extension
Nov 18, 2021
Total Funding Raised
$26M
Company Overview
Fountain Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A Extension round in November 2021.
Fountain Therapeutics is a biotechnology company that develops targeted therapeutics to reverse cellular aging and treat age-related diseases using an artificial intelligence-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fountain Therapeutics Comparables
Compare Fountain Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gero | 82% | |
| Recursion Pharmaceuticals | 80% | |
| Verge Labs | 77% |
For institutional investors. Book with your work email.
Fountain Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 18, 2021 | ||||
| Series A Extension | May 19, 2020 | ||||
| Series A | May 1, 2018 |
For institutional investors. Book with your work email.
Fountain Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series A Extension |
| Nan Fung Life Sciences | Series A Extension, Series A |
| Alexandria Venture Investments | Series A Extension |
| R42 Group | Series A Extension |
| Alexandria Venture Investments | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2021
$15M raised with participation from Khosla Ventures.
- May 1, 2018
$5M round led by Nan Fung Life Sciences
For institutional investors. Book with your work email.
Fountain Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fountain Therapeutics's valuation, stock price, and market status.
Is Fountain Therapeutics a public or private company?
Fountain Therapeutics is a private company.
What is the current stock price of Fountain Therapeutics?
Fountain Therapeutics is a private company, so its shares have no public market price. Caplight tracks Fountain Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fountain Therapeutics worth (valuation)?
Valuation information for Fountain Therapeutics is not publicly available.
Can I buy Fountain Therapeutics stock?
Fountain Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fountain Therapeutics's last funding round?
Fountain Therapeutics's most recent funding round was Series A Extension on November 18, 2021.
Who are the main investors in Fountain Therapeutics?
Key investors in Fountain Therapeutics include Khosla Ventures, Nan Fung Life Sciences.
Will Fountain Therapeutics IPO soon?
No public IPO plans have been announced for Fountain Therapeutics.
How can I track Fountain Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Fountain Therapeutics's shares on secondary markets.